NCT02182232View on ClinicalTrials.gov

A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2007

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

BIBF 1120

DRUG

Paclitaxel

DRUG

Carboplatin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY